Key result
Routine 10% stent oversizing during STEMI PCI fails to improve complete ST-segment resolution.
Why the study?
Although routine stent oversizing has shown promise to prevent undersizing from spasm and catecholamine release during primary PCI for STEMI, it had never been evaluated in randomized clinical trials.
Does routine stent oversizing by 10% improve ST-segment resolution and TIMI flow in patients with STEMI undergoing primary PCI?
RCT (n=122)
Open-label
No
Does routine stent oversizing by 10% improve ST-segment resolution and TIMI flow in patients with STEMI undergoing primary PCI?
Routine stent oversizing by 10% during primary PCI for STEMI does not improve angiographic, electrocardiographic, or clinical outcomes compared to standard sizing.
Answers are grounded in this paper and cite their sources.
No benefit from routine 10% oversizing in STEMI primary PCI; reinforces standard sizing and does not support adoption.
BACKGROUND: In patients with ST-segment-elevation myocardial infarction (STEMI), primary percutaneous coronary intervention (PPCI) is the treatment of choice. Stent undersizing might occur due to catecholamine release and coronary spasm. Although routine oversizing has been promising in several investigations, it has never been tested in randomized clinical trials. In this single-center open-label randomized clinical trial, we evaluated the role of stent oversizing in PPCI. METHODS: Candidates for PPCI were randomly divided into oversized and non-oversized groups. In the oversized group, the stent was oversized by 10% according to the mean lumen diameter, retrieved from the quantitative coronary analysis. Primary composite endpoints were defined as the occurrence of complete total ST-segment (STR)resolution and postprocedural thrombolysis in myocardial infarction (TIMI) flow grade III. RESULTS: The study population was comprised of 122 patients, allocated to the oversized group (N.=61) and the non-oversized group (N.=61). There was no significant difference between the 2 groups regarding the final TIMI flow grade. Complete STR was marginally more favorable in the non-oversized group (56.05±55.12 vs. 64.64±23.28; P=0.056). The troponin ratio, CK-MB ratio, and 6-month follow-up outcome - defined as target lesion revascularization, heart failure, and cardiovascular death - were comparable between the 2 groups. CONCLUSIONS: Our study showed that routine oversizing in patients undergoing PPCI had no benefit regarding ST-segment resolution and the final TIMI flow, as well as hard cardiac events, during the follow-up.
No takes yet. Share an insight, caveat, or question.
Banifatemeh et al. (2020) conducted an RCT in ST-segment-elevation myocardial infarction (STEMI) (n=122). Stent oversizing vs. Non-oversized stent was evaluated on Complete total ST-segment (STR) resolution and postprocedural thrombolysis in myocardial infarction (TIMI) flow grade III (p=0.056). Routine stent oversizing by 10% in STEMI patients undergoing primary PCI showed no significant benefit for complete ST-segment resolution compared to non-oversizing.
Synapse has enriched 10 related papers. Consider them for comparative context: